The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy

by Alexandra S. Troyan, Oleg A. Levada
Published 2020-08-01

Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder

by Oleg A. Levada, Alexandra S. Troyan
Published 2017-10-01

Poststroke Depression Biomarkers: A Narrative Review

by Oleg A. Levada, Alexandra S. Troyan
Published 2018-07-01

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine st...

by Oleg A. Levada, Alexandra S. Troyan, Irina Y. Pinchuk
Published 2020-05-01

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study

by Oleg A. Levada, Nataliya V. Cherednichenko, Alexandra S. Troyan
Published 2017-05-01

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

by Oleg A. Levada, Nataliya V. Cherednichenko, Andriy V. Trailin, Alexandra S. Troyan
Published 2016-01-01